N

Cryoablation of Osseous Metastases

By Navid Eghbalieh
319 views
February 14, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

19:22
Janssen Oncology

Doc Talk Podcast

Feat. J. Hamilton, M. Fabrizio, M. Taha

Featured Video

20:25
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Related Content

AUTOPLAY
32:36
Ibrahim Sahin

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

39:40
Ibrahim Sahin

Young Onset Colorectal Cancer: A New Epidemic?

17:19
Moffitt Cancer Center

Year in Review: Colorectal Cancer

Feat. R. Kim, T. Biachi
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
11:56
Ana Aparicio

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

25:23
Houston Methodist Hospital

Whole-Body MRI: Past, Present, and Future

Feat. N. Gupta
13:04
Douglas Beall

Spinal Tumor Ablation and Vertebral Augmentation for Treatment of Pa…

14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

19:48
Florida Gastroenterologic Society

Colon Polyp with Carcinoma In-Situ, Intramucosal Cancer or Invasive …

Feat. D. Yang
13:37
SIR 2023 Conference Coverage

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
27:04
Fengting Yan

Cancer Screening Molecular Tools

21:20
Jason Levy

Spine Ablation in 2023: Indications, Goals, Guidelines, Evidence, an…

15:58
Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers
05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
09:32
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "ctDNA in Colon Cancer - GALAXY…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold